Accendra Health (ACH) Earnings Analysis

Accendra Health (ACH) next reports earnings on 2026-08-10, consensus EPS -0.13 USD. Last quarter (2026-05-11) it beat with EPS -0.04 USD vs -0.06 USD est (+33.3%). It has beaten estimates in 6/8 recent quarters (75%). Trailing P/E -0.22.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ACH next report earnings?

Next earnings date2026-08-10
Consensus EPS estimate-0.13 USD
Revenue estimate0.63B

ACH earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-11-0.04 USD-0.06 USD+33.3%Beat
2026-02-190.21 USD0.22 USD-4.5%Miss
2025-10-300.25 USD0.23 USD+8.7%Beat
2025-08-110.26 USD0.27 USD-3.7%Miss
2025-05-080.23 USD0.2 USD+15%Beat
2025-02-280.55 USD0.53 USD+3.8%Beat
2024-11-040.42 USD0.4 USD+5%Beat
2024-08-020.36 USD0.33 USD+9.1%Beat

Beat rate: 6/8 (75%) over reported quarters with consensus data.

ACH valuation and analyst view

Trailing P/E-0.22
Trailing EPS-14.10876 USD
Price / book-0.52
Dividend yield0.00%
Market cap0.25B
Analyst consensusHold (3 buy / 10 hold / 2 sell)
Avg price target5.25 USD

Related research pages

Frequently asked questions

When is Accendra Health (ACH)'s next earnings date?

Accendra Health is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.13 USD and revenue estimate of 0.63B.

Did ACH beat earnings last quarter?

In its 2026-05-11 report, ACH posted EPS of -0.04 USD versus a -0.06 USD estimate — a beat of 33.3%.

What is ACH's earnings track record?

Over the last 8 reported quarters with consensus data, ACH beat estimates 6 times (75%).

What is ACH's current P/E ratio and EPS?

ACH trades at a trailing P/E of -0.22 on trailing EPS of -14.108762826112466 USD.

What do analysts rate ACH?

Analyst consensus is "Hold" across 15 ratings (0 strong buy, 3 buy, 10 hold, 2 sell, 0 strong sell). Average 12-month price target: 5.25 USD.